Peregrine Pharma (PPHM) Reports Q4 Loss of $0.16/Share

Peregrine Pharma (NASDAQ: PPHM) reported Q4 EPS of ($0.16), versus ($0.40) reported last year. Revenue for the quarter came in at $17.9 million, versus $18.78 million reported last year.

For earnings history and earnings-related data on Peregrine Pharma (PPHM) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Deere & Co. (DE) Tops Q3 EPS by 41c, raises guidance
• Ubiquiti (UI) Tops Q4 EPS by 25c, Beats on Revenue